| Indicators | Browse All

Accuray Incorporated (ARAY)

Healthcare | Medical Devices | Madison, United States | NasdaqCM
0.19 USD -0.03 (-12.826%) ⇩ (Oct. 13, 2026, 4 p.m. EDT)
After hours: 0.19 0.00 (0.000%) ⇩ (Oct. 13, 2026, 6:56 p.m. EDT)

Short-term:★☆☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 9:22 a.m. EDT

The investment case for Accuray is currently broken on both the immediate and long-term fronts, driven by a perfect storm of deteriorating fundamentals and a hostile market structure. Long-term, the business is failing to generate value. Revenue has contracted by nearly 21% year-over-year, and the company is bleeding cash with negative operating cash flow and a massive debt load relative to equity. The stock has lost over 70% of its value over the last nine years, and despite a slight uptick in the most recent annual comparison, the trailing twelve months show a 33% drop in share price. The market has correctly identified this as a value trap; the low price-to-book ratio is not a bargain, but a reflection of the company's inability to sustain operations. With no dividend to provide income, there is no floor for the downside other than bankruptcy or acquisition at a distressed price. Short-term, the momentum is decisively negative. The stock is trading significantly below its 50-day and 200-day moving averages, confirming a prolonged downtrend. The options market offers no hope for a bounce; the complete absence of call buying suggests that even traders are not willing to risk capital on a reversal. Instead, the heavy put open interest at the $0.50 strike acts as a self-fulfilling prophecy, capping any potential rally. The statistical forecasting models also register a weak signal, aligning with the broader picture of uncertainty and lack of direction. In summary, Accuray presents a high-risk profile with no catalyst for recovery visible in the data. The combination of shrinking revenues, deep losses, and a stock price that has halved in the last year makes it a clear 'avoid' for both swing traders and long-term holders.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.137369
AutoARIMA0.141865
MSTL0.145121
AutoTheta0.265139

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 37%
H-stat 0.26
Ljung-Box p 0.000
Jarque-Bera p 0.630
Excess Kurtosis -0.70
Attribute Value
Sector Healthcare
Debt to Equity Ratio 440.955
Revenue per Share 3.278
Market Cap 22,729,300
Forward P/E -0.79
Beta 1.42
Profit Margins -12.24%
Website https://www.accuray.com

As of Oct. 10, 2026, 9:22 a.m. EDT: Speculators are overwhelmingly positioned for downside protection rather than upside speculation. Call activity is virtually nonexistent across all expirations, with zero volume or open interest recorded for strikes above the money. Conversely, put buyers are active, particularly at the $0.50 strike, which represents a significant distance from current prices. This heavy skew toward selling puts indicates a market consensus expecting further weakness or stagnation, with no speculative capital attempting to bet on a recovery.


Info Dump

Attribute Value
52 Week Change -0.878453
Address1 1,240 Deming Way
All Time High 31.09
All Time Low 0.21
Ask 0.2153
Ask Size 1
Audit Risk 10
Average Daily Volume10 Day 3,535,360
Average Daily Volume3 Month 7,285,538
Average Volume 7,285,538
Average Volume10Days 3,535,360
Beta 1.419
Bid 0.1608
Bid Size 1
Board Risk 5
Book Value 0.349
City Madison
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 5
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.1903
Current Ratio 1.503
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 0.2148
Day Low 0.1855
Debt To Equity 440.955
Display Name Accuray
Dividend Yield 0.0
Earnings Call Timestamp End 1,787,171,400
Earnings Call Timestamp Start 1,787,171,400
Earnings Timestamp 1,787,169,600
Earnings Timestamp End 1,793,822,400
Earnings Timestamp Start 1,793,822,400
Ebitda -3,528,000
Ebitda Margins -0.00878
Enterprise To Ebitda -47.047
Enterprise To Revenue 0.413
Enterprise Value 165,980,304
Eps Forward -0.24
Eps Trailing Twelve Months -0.4
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 608 824 2996
Fifty Day Average 0.2646
Fifty Day Average Change -0.074300006
Fifty Day Average Change Percent -0.28080124
Fifty Two Week Change Percent -87.8453
Fifty Two Week High 1.86
Fifty Two Week High Change -1.6697
Fifty Two Week High Change Percent -0.89768815
Fifty Two Week Low 0.1855
Fifty Two Week Low Change 0.0048000067
Fifty Two Week Low Change Percent 0.025876047
Fifty Two Week Range 0.1855 - 1.86
Financial Currency USD
First Trade Date Milliseconds 1,170,945,000,000
Float Shares 113,610,669
Forward Eps -0.24
Forward P E -0.7929167
Free Cashflow 10,565,625
Full Exchange Name NasdaqCM
Full Time Employees 809
Fullday Change -0.028400004
Fullday Change Percent -13.009622
Fullday Price 0.1903
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,790,812,800
Gross Margins 0.27729
Gross Profits 111,454,000
Has Pre Post Market Data 1
Held Percent Insiders 0.04235
Held Percent Institutions 0.64609003
Implied Shares Outstanding 119,439,307
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Ir Website http://investors.accuray.com/phoenix.zhtml?c=177244&p=irol-irhome
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,782,777,600
Long Business Summary Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, a tailored helical solution, which integrates radiation treatment planning, delivery, imaging, and data management; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Long Name Accuray Incorporated
Market us_market
Market Cap 22,729,300
Market State PREPRE
Max Age 86,400
Message Board Id finmb_739115
Most Recent Quarter 1,782,777,600
Net Income To Common -49,194,000
Next Fiscal Year End 1,814,313,600
Non Diluted Market Cap 26,951,479
Open 0.212
Operating Cashflow -6,981,000
Operating Margins 0.062140003
Overall Risk 6
Payout Ratio 0.0
Peg Ratio 29.49
Phone 608 824 2800
Post Market Change -0.00040000677
Post Market Change Percent -0.21019799
Post Market Price 0.1899
Post Market Time 1,791,932,171
Previous Close 0.2183
Price Hint 4
Price To Book 0.54527223
Price To Sales Trailing12 Months 0.056548003
Profit Margins -0.12239
Quick Ratio 0.661
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.028
Regular Market Change Percent -12.8264
Regular Market Day High 0.2148
Regular Market Day Low 0.1855
Regular Market Day Range 0.1855 - 0.2148
Regular Market Open 0.212
Regular Market Previous Close 0.2183
Regular Market Price 0.1903
Regular Market Time 1,791,921,601
Regular Market Volume 3,243,480
Return On Assets -0.014049999
Return On Equity -0.80076
Revenue Growth -0.209
Revenue Per Share 3.278
Sand P52 Week Change 0.17502642
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 5
Shares Outstanding 119,439,307
Shares Percent Shares Out 0.0619
Shares Short 7,388,578
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 4,993,743
Short Name Accuray Incorporated
Short Percent Of Float 0.0709
Short Ratio 0.4
Source Interval 15
State WI
Symbol ARAY
Total Cash 40,623,000
Total Cash Per Share 0.34
Total Debt 183,874,000
Total Revenue 401,947,008
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.4
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 0.4184
Two Hundred Day Average Change -0.22809999
Two Hundred Day Average Change Percent -0.5451721
Type Disp Equity
Volume 3,243,480
Website https://www.accuray.com
Zip 53,717-1954